These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23590913)

  • 21. Transfusion medicine: A research agenda for the coming years.
    Blumberg N; Cholette JM; Cahill C; Pietropaoli AP; Winters S; Phipps R; Noronha SA; Heal JM; Kirkley SA; Fountaine TJ; Henrichs K; Masel D; Refaai MA
    Transfus Apher Sci; 2019 Oct; 58(5):698-700. PubMed ID: 31402101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transfusion of blood and products derived from blood].
    Wautier JL
    Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
    [No Abstract]   [Full Text] [Related]  

  • 23. [Importance of haemovigilance and reports on transfusion reaction in blood component therapy].
    Grujić J; Gulan Z; Budakov Z
    Med Pregl; 2012; 65(1-2):50-3. PubMed ID: 22452240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood transfusion risks and alternative strategies in pediatric patients.
    Lavoie J
    Paediatr Anaesth; 2011 Jan; 21(1):14-24. PubMed ID: 21155923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adverse effects due to unstable blood products].
    Hauser SP; Nydegger UE
    Schweiz Med Wochenschr; 1996 Apr; 126(15):637-45. PubMed ID: 8668979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Online reporting system for transfusion-related adverse events to enhance recipient haemovigilance in Japan: a pilot study.
    Odaka C; Kato H; Otsubo H; Takamoto S; Okada Y; Taneichi M; Okuma K; Sagawa K; Hoshi Y; Tasaki T; Fujii Y; Yonemura Y; Iwao N; Tanaka A; Okazaki H; Momose SY; Kitazawa J; Mori H; Matsushita A; Nomura H; Yasoshima H; Ohkusa Y; Yamaguchi K; Hamaguchi I
    Transfus Apher Sci; 2013 Feb; 48(1):95-102. PubMed ID: 22954634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood and plasma transfusion in the treatment of acute blood loss].
    Hiippala S
    Duodecim; 2004; 120(7):893-901. PubMed ID: 15154311
    [No Abstract]   [Full Text] [Related]  

  • 28. [Risk of immunization to blood cells and diagnostic and therapeutic implications].
    Kiefel V
    Beitr Infusionsther; 1993; 31():44-51. PubMed ID: 7693263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute transfusion reactions.
    Henderson RA; Pinder L
    N Z Med J; 1990 Oct; 103(900):509-11. PubMed ID: 2234645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein cross-match test for the diagnosis and prevention of reactions after the transfusion of blood and cryoprecipitate.
    Pintera J; Vacl J; Valnícek S; Hill Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):544-51. PubMed ID: 83277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of risks related to blood transfusions in industrialized countries].
    Salamon R; Lawson-Ayayi S; Salmi LR
    Rev Epidemiol Sante Publique; 1994; 42(5):408-15. PubMed ID: 7973000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety incident reports associated with blood transfusions.
    Vossoughi S; Perez G; Whitaker BI; Fung MK; Rajbhandary S; Crews N; Stotler B
    Transfusion; 2019 Sep; 59(9):2827-2832. PubMed ID: 31254465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on transfusion medicine.
    Shander A; Goodnough LT
    Pharmacotherapy; 2007 Sep; 27(9 Pt 2):57S-68S. PubMed ID: 17723109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogenic blood transfusion in cardiac surgery.
    Crescenzi G; Torracca L; Capestro F; Matteucci ML; Rossi M
    J Card Surg; 2012 Sep; 27(5):594-9. PubMed ID: 22978836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative risks of early fresh frozen plasma, cryoprecipitate and platelet transfusion in Europe.
    Norda R; Tynell E; Akerblom O
    J Trauma; 2006 Jun; 60(6 Suppl):S41-5. PubMed ID: 16763480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunohematologic and patient safety benefits of a centralized transfusion database.
    Delaney M; Dinwiddie S; Nester TN; Aubuchon JA
    Transfusion; 2013 Apr; 53(4):771-6. PubMed ID: 22803792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of blood transfusions].
    Blot P
    Soins Chir Gen Spec; 1982 Apr; (14):17-20. PubMed ID: 6979786
    [No Abstract]   [Full Text] [Related]  

  • 38. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Error management of emergency transfusions: a surveillance system to detect safety risks in day to day practice.
    Schmidt-Hieber M; Schuster R; Nogai A; Thiel E; Hopfenmüller W; Notter M
    Transfus Apher Sci; 2006 Oct; 35(2):125-30. PubMed ID: 17045844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
    Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
    Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.